Hero Image Swim

100% of your gift funds life-changing programs.

Help families living with MS thrive.



Can Do MS delivers health and wellness education programs to help families living with MS thrive.


FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis

BrainStorm Cell Therapeutics Inc. announced that the U.S. Food and Drug Administration has accepted the Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of NurOwn® for the treatment of progressive multiple sclerosis.

​Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis

Diroximel fumarate was designed to provide patients with relapsing forms of multiple sclerosis a novel oral fumarate with a differentiated profile. The data encompassed in the regulatory package underscore diroximel fumarate’s potential to be a meaningful, new treatment option for the MS community.

Can Do MS Retains Highest Recognition from Charity Navigator

This is the 10th time that Can Do MS has earned a 4-star rating from Charity Navigator, showing the organization uses donor dollars in a fiscally responsible way to further its mission of delivering health and wellness education programs that help families with MS thrive.

Jack Osbourne, Star of "You Don't Know Jack About MS," Opens Up About His MS Journey

Recently, Can Do MS had the chance to chat with reality star and television personality, Jack Osbourne. Jack is 33 years-old, father of three, and has been living with MS for 5 years. After his diagnosis, Jack partnered with Teva Neuroscience to create the web series You Don’t Know Jack About MS